Neuronetics closes Greenbrook TMS acquisition; adds 2 directors; secures $10M loan amendment.

Neuronetics, Inc.

Acquisition closed Dec 9; exchange ratio 0.01021 Neuronetics share per Greenbrook share; Greenbrook to delist from OTCQB.
Madryn converted ~2.06B Greenbrook Shares from credit agreement and ~253M from interim funding, receiving Neuronetics shares at exchange ratio.
Board expanded to 7; appointed Sasha Cucuz (Greybrook CEO) and Dr. Avinash Amin (Madryn managing partner).
Credit agreement with Perceptive amended to allow $10M Tranche 3 loan for combined operations and new revenue covenants; warrant for 600k shares issued.
Combined company to operate as Neuronetics (STIM); integration targeting cost synergies and profitable growth.

item 1.01 item 2.01 item 3.02 item 5.02 item 5.03 item 8.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.